• 1
    Lindblad, E. B., Aluminium compounds for use in vaccines. Immunol. Cell Biol. 2004 82: 497505.
    Direct Link:
  • 2
    Mannhalter, J. W., Neychev, H. O., Zlabinger, G. J., Ahmad, R. and Eibl, M. M., Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: Effect on antigen uptake and antigen presentation. Clin. Exp. Immunol. 1985 61: 143151.
  • 3
    Sokolovska, A., Hem, S. L. and HogenEsch, H., Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine 2007 25: 45754585.
  • 4
    Li, H., Nookala, S. and Re, F., Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J. Immunol. 2007 178: 52715276.
  • 5
    Kool, M., Soullie, T., van Nimwegen, M., Willart, M. A., Muskens, F., Jung, S., Hoogsteden, H. C. et al., Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 2008 205: 869882.
  • 6
    Ishii, K. J. and Akira, S., Toll or toll-free adjuvant path toward the optimal vaccine development. J. Clin. Immunol. 2007 27: 363371.
  • 7
    Akira, S., Uematsu, S. and Takeuchi, O., Pathogen recognition and innate immunity. Cell 2006 124: 783801.
  • 8
    Uematsu, S. and Akira, S., Toll-like receptors and type I interferons. J. Biol. Chem. 2007 282: 1531915323.
  • 9
    Pasare, C. and Medzhitov, R., Control of B-cell responses by Toll-like receptors. Nature 2005 438: 364368.
  • 10
    Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B. and Nemazee, D., Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 2006 314: 19361938.
  • 11
    Franchi, L., Park, J. H., Shaw, M. H., Marina-Garcia, N., Chen, G., Kim, Y. G. and Nunez, G., Intracellular NOD-like receptors in innate immunity, infection and disease. Cell. Microbiol. 2008 10: 18.
  • 12
    Franchi, L., McDonald, C., Kanneganti, T. D., Amer, A. and Nunez, G., Nucleotide-binding oligomerization domain-like receptors: Intracellular pattern recognition molecules for pathogen detection and host defense. J. Immunol. 2006 177: 35073513.
  • 13
    Kim, Y. G., Park, J. H., Shaw, M. H., Franchi, L., Inohara, N. and Nunez, G., The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 2008 28: 246257.
  • 14
    Marina-Garcia, N., Franchi, L., Kim, Y. G., Miller, D., McDonald, C., Boons, G. J. and Nunez, G., Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 2008 180: 40504057.
  • 15
    Kanneganti, T. D., Lamkanfi, M., Kim, Y. G., Chen, G., Park, J. H., Franchi, L., Vandenabeele, P. and Nunez, G., Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007 26: 433443.
  • 16
    Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J., Gout-associated uric acid crystals activate the Nalp3 inflammasome. Nature 2006 440: 237241.
  • 17
    Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P. et al., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440: 228232.
  • 18
    Kanneganti, T. D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J. H., Franchi, L., Whitfield, J. et al., Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006 440: 233236.
  • 19
    Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J. et al., Critical role for Nalp3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006 24: 317327.
  • 20
    Qu, Y., Franchi, L., Nunez, G. and Dubyak, G. R., Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 2007 179: 19131925.
  • 21
    Brough, D. and Rothwell, N. J., Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death. J. Cell Sci. 2007 120: 772781.
  • 22
    Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T. and Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008 320: 674677.
  • 23
    Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. and Flavell, R. A., Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008. DOI 10.1038/nature06939.
  • 24
    Kanneganti, T. D., Body-Malapel, M., Amer, A., Park, J. H., Whitfield, J., Franchi, L., Taraporewala, Z. F. et al., Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006 281: 3656036568.
  • 25
    Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T. D., Ozoren, N., Jagirdar, R., Inohara, N. et al., Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in Salmonella-infected macrophages. Nat. Immunol. 2006 7: 576582.
  • 26
    Ozoren, N., Masumoto, J., Franchi, L., Kanneganti, T. D., Body-Malapel, M., Erturk, I., Jagirdar, R. et al., Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18 secretion in response to Listeria monocytogenes. J. Immunol. 2006 176: 43374342.
  • 27
    Amer, A., Franchi, L., Kanneganti, T. D., Body-Malapel, M., Ozoren, N., Brady, G., Meshinchi, S. et al., Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J. Biol. Chem. 2006 281: 3521735223.